Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Verrica Pharmaceuticals (VRCA) Long-Term Debt Issuances (2021)

Verrica Pharmaceuticals has reported Long-Term Debt Issuances over the past 1 years, most recently at $5.0 million for Q1 2021.

  • Quarterly results put Long-Term Debt Issuances at $5.0 million for Q1 2021, changed N/A from a year ago — trailing twelve months through Dec 2021 was $5.0 million (changed N/A YoY), and the annual figure for FY2023 was $44.1 million, changed.
  • Long-Term Debt Issuances for Q1 2021 was $5.0 million at Verrica Pharmaceuticals.
  • Over the last five years, Long-Term Debt Issuances for VRCA hit a ceiling of $5.0 million in Q1 2021 and a floor of $5.0 million in Q1 2021.